This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
Class action litigation continues to expand in both number of filings and monetary exposure, with se...
This presentation aims to explore various models and cases of artificial intelligence use in healthc...
This program provides trial attorneys with a thorough grounding in the three principal currency repo...
Every IP question a client brings starts with two decisions: which regime (patent, trademark, copyri...
This program examines the scope, jurisdiction, and exceptions to the Federal Arbitration Act (FAA), ...
Join us for this presentation to learn about the U.S. Court of Appeals for the Federal Circuit litig...
Incorrect military records prevent active duty and reserve Soldiers, Airmen, Guardians, Marines, Sai...
The United States Constitution is one of the most influential legal documents in history, establishi...
This course analyzes federal titling and indexing requirements and how to expunge or amend your reco...
Class action waivers in arbitration agreements remain enforceable, but a decade of U.S. Supreme Cour...